ID   NMNA2_RAT               Reviewed;         307 AA.
AC   Q0HA29;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 1.
DT   24-JUL-2024, entry version 114.
DE   RecName: Full=Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 {ECO:0000305};
DE            Short=NMN/NaMN adenylyltransferase 2;
DE            EC=2.7.7.1 {ECO:0000250|UniProtKB:Q9BZQ4};
DE            EC=2.7.7.18 {ECO:0000250|UniProtKB:Q9BZQ4};
DE   AltName: Full=Nicotinamide mononucleotide adenylyltransferase 2;
DE            Short=NMN adenylyltransferase 2;
DE   AltName: Full=Nicotinate-nucleotide adenylyltransferase 2;
DE            Short=NaMN adenylyltransferase 2;
GN   Name=Nmnat2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Xing J., Cao G., Zhang L., Chen J.;
RT   "Nicotinamide nucleotide adenylyltransferase is neuroprotective against
RT   ischemic injury.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Nicotinamide/nicotinate-nucleotide adenylyltransferase that
CC       acts as an axon maintenance factor (By similarity). Axon survival
CC       factor required for the maintenance of healthy axons: acts by delaying
CC       Wallerian axon degeneration, an evolutionarily conserved process that
CC       drives the loss of damaged axons (By similarity). Catalyzes the
CC       formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Can
CC       also use the deamidated form; nicotinic acid mononucleotide (NaMN) as
CC       substrate but with a lower efficiency. Cannot use triazofurin
CC       monophosphate (TrMP) as substrate. Also catalyzes the reverse reaction,
CC       i.e. the pyrophosphorolytic cleavage of NAD(+). For the
CC       pyrophosphorolytic activity prefers NAD(+), NADH and NaAD as substrates
CC       and degrades nicotinic acid adenine dinucleotide phosphate (NHD) less
CC       effectively. Fails to cleave phosphorylated dinucleotides NADP(+),
CC       NADPH and NaADP(+). Also acts as an activator of ADP-ribosylation by
CC       supporting the catalytic activity of PARP16 and promoting mono-ADP-
CC       ribosylation of ribosomes by PARP16 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BNJ3, ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + beta-nicotinamide D-ribonucleotide + H(+) = diphosphate
CC         + NAD(+); Xref=Rhea:RHEA:21360, ChEBI:CHEBI:14649, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57540; EC=2.7.7.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21361;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21362;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H(+) + nicotinate beta-D-ribonucleotide = deamido-NAD(+)
CC         + diphosphate; Xref=Rhea:RHEA:22860, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57502,
CC         ChEBI:CHEBI:58437; EC=2.7.7.18;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22861;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:22862;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9BZQ4};
CC       Note=Divalent metal cations. Mg(2+) confers the highest activity.
CC       {ECO:0000250|UniProtKB:Q9BZQ4};
CC   -!- ACTIVITY REGULATION: Inhibited by P1-(adenosine-5')-P3-(nicotinamide-
CC       riboside-5')-triphosphate (Np3AD) and P1-(adenosine-5')-P4-
CC       (nicotinamide-riboside-5')-tetraphosphate (Np4AD).
CC       {ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from
CC       nicotinamide D-ribonucleotide: step 1/1.
CC       {ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-NAD(+)
CC       from nicotinate D-ribonucleotide: step 1/1.
CC       {ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q8BNJ3}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q8BNJ3}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:Q8BNJ3}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q8BNJ3}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9BZQ4}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q8BNJ3}. Note=Delivered to axons with Golgi-
CC       derived cytoplasmic vesicles. {ECO:0000250|UniProtKB:Q8BNJ3}.
CC   -!- PTM: Degraded in response to injured neurite (By similarity).
CC       Degradation is caused by polyubiquitination by MYCBP2 after recognition
CC       by FBXO45 (By similarity). {ECO:0000250|UniProtKB:Q8BNJ3,
CC       ECO:0000250|UniProtKB:Q9BZQ4}.
CC   -!- PTM: Palmitoylated; palmitoylation is required for membrane
CC       association. {ECO:0000250|UniProtKB:Q8BNJ3}.
CC   -!- SIMILARITY: Belongs to the eukaryotic NMN adenylyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ022370; AAY87457.1; -; mRNA.
DR   RefSeq; NP_001041507.1; NM_001048042.1.
DR   AlphaFoldDB; Q0HA29; -.
DR   SMR; Q0HA29; -.
DR   STRING; 10116.ENSRNOP00000029020; -.
DR   PhosphoSitePlus; Q0HA29; -.
DR   SwissPalm; Q0HA29; -.
DR   PaxDb; 10116-ENSRNOP00000029020; -.
DR   GeneID; 289095; -.
DR   KEGG; rno:289095; -.
DR   UCSC; RGD:1307331; rat.
DR   AGR; RGD:1307331; -.
DR   CTD; 23057; -.
DR   RGD; 1307331; Nmnat2.
DR   eggNOG; KOG3199; Eukaryota.
DR   InParanoid; Q0HA29; -.
DR   OrthoDB; 5488885at2759; -.
DR   PhylomeDB; Q0HA29; -.
DR   Reactome; R-RNO-196807; Nicotinate metabolism.
DR   UniPathway; UPA00253; UER00332.
DR   UniPathway; UPA00253; UER00600.
DR   PRO; PR:Q0HA29; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005770; C:late endosome; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; ISO:RGD.
DR   GO; GO:0140768; F:protein ADP-ribosyltransferase-substrate adaptor activity; ISS:UniProtKB.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0009435; P:NAD biosynthetic process; IMP:RGD.
DR   GO; GO:2000766; P:negative regulation of cytoplasmic translation; ISO:RGD.
DR   CDD; cd09286; NMNAT_Eukarya; 1.
DR   Gene3D; 3.40.50.620; HUPs; 1.
DR   InterPro; IPR004821; Cyt_trans-like.
DR   InterPro; IPR051182; Euk_NMN_adenylyltrnsfrase.
DR   InterPro; IPR045094; NMNAT_euk.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   PANTHER; PTHR12039; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; 1.
DR   PANTHER; PTHR12039:SF18; NICOTINAMIDE_NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE 2; 1.
DR   Pfam; PF01467; CTP_transf_like; 1.
DR   SUPFAM; SSF52374; Nucleotidylyl transferase; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell projection; Cytoplasm; Cytoplasmic vesicle;
KW   Golgi apparatus; Lipoprotein; Membrane; NAD; Nucleotide-binding;
KW   Nucleotidyltransferase; Palmitate; Pyridine nucleotide biosynthesis;
KW   Reference proteome; Transferase; Ubl conjugation.
FT   CHAIN           1..307
FT                   /note="Nicotinamide/nicotinic acid mononucleotide
FT                   adenylyltransferase 2"
FT                   /id="PRO_0000328662"
FT   BINDING         16
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         17
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         24
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         92
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         95
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         200
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         202
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         212
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         213
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         232
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   BINDING         271..274
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T66"
FT   LIPID           164
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BNJ3"
FT   LIPID           165
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BNJ3"
SQ   SEQUENCE   307 AA;  34445 MW;  EDE5DAB7B03AE1AA CRC64;
     MTETTKTHVI LLACGSFNPI TKGHIQMFER ARDYLHKTGR FIVIGGIVSP VHDSYGKQGL
     VSSRHRLIMC QLAVQNSDWI RVDPWECYQD TWQTTCSVLE HHRDLMKRVT GCILSNVNTP
     SMTPVIGQPQ HENTQPIYQN SNVPTKPTAA KILGKVGESL GRICCVRPPV ERFTFVDENA
     NLGTVMRYEE IELRILLLCG SDLLESFCIP GLWNEADMEV IVGDFGIVVV PRDAADADRI
     MNHSSILRKY KNNIMVVKDD INHPMSVVSS TKSRLALQHG DGHVVDYLSQ PVIDYILKSQ
     LYINASG
//
